ClinConnect ClinConnect Logo
Search / Trial NCT04546230

Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy.

Launched by NAZMY EDWARD SEIF · Sep 6, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Epidural Anesthesia Low Thoracic Laparoscopic Nephrectomy

ClinConnect Summary

This clinical trial is studying the use of a specific type of anesthesia called epidural anesthesia for patients undergoing laparoscopic nephrectomy, which is a minimally invasive surgery to remove a kidney. The goal is to see how epidural anesthesia compares to the usual general anesthesia in terms of patient comfort and safety during the surgery. Researchers believe that using epidural anesthesia might lead to less pain after surgery and fewer complications, especially for older or higher-risk patients.

To participate in this trial, you would need to be an adult scheduled for laparoscopic nephrectomy and classified as having a low to moderate risk for anesthesia (ASA I-II). However, if you have certain medical conditions that prevent the use of regional anesthesia, or if you are allergic to local anesthetics, you wouldn’t be eligible. If you join the study, you can expect to receive either the epidural anesthesia or the standard general anesthesia during your surgery, and the research team will monitor your recovery to compare the outcomes. This trial is currently looking for participants, so if you're interested, it's a good idea to discuss it with your doctor.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA I - II.
  • Adult patients scheduled for laparoscopic nephrectomy.
  • Exclusion Criteria:
  • Patient refusal.
  • Contraindication to regional anesthesia (e.g., coagulopathy, site infection).
  • Allergy to local anesthetics.

About Nazmy Edward Seif

Nazmy Edward Seif is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, the organization collaborates with leading healthcare professionals and institutions to design and execute rigorous clinical studies. Emphasizing patient safety and ethical standards, Nazmy Edward Seif strives to facilitate the seamless transition of groundbreaking therapies from the laboratory to clinical practice, ultimately aiming to improve patient outcomes and enhance public health.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Nazmy S Michael, MD

Principal Investigator

Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University

Atef K Salama, MD

Study Director

Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials